CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-06 | Heffernan Michael Thomas Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2019-06-06 | GOWEN MAXINE Director | Grant or award | +13,700 | 15,000 | ||
| 2019-06-06 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2019-06-06 | GILMAN STEVEN C Director | Grant or award | +13,700 | 23,931 | ||
| 2019-06-06 | GILMAN STEVEN C Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2019-06-06 | Enyedy Mark J Director | Grant or award | +13,700 | 17,443 | ||
| 2019-06-06 | Enyedy Mark J Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2019-06-06 | Canute Scott A Director | Grant or award | +13,700 | 13,700 | ||
| 2019-06-06 | Canute Scott A Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2019-06-06 | ADAMS ADRIAN Director | Grant or award | +13,700 | 13,700 | ||
| 2019-06-06 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2019-06-03 | Butler John P. CEO and President | Option exercise | +287,000 | $0.47 | $135K | 836,232 |
| 2019-06-03 | Butler John P. CEO and President | Option exercise · Employee Stock Option (Right to buy) | −287,000 | 0 | ||
| 2019-05-31 | Faulkingham Dell CCO | Grant or award | +25,000 | 25,000 | ||
| 2019-05-31 | Faulkingham Dell CCO | Grant or award · Employee Stock Option (Right to buy) | +250,000 | 250,000 | ||
| 2019-04-11 | Jain Rita SVP, Chief Medical Officer | Returned to the company | −4,409 | $7.70 | $34K | 96,332 |
| 2019-04-11 | Dahan Michel SVP, Chief Business Officer | Returned to the company | −11,909 | $7.70 | $92K | 146,932 |
| 2019-04-11 | Hadas Nicole R. SVP, CLO & Secretary | Returned to the company | −11,929 | $7.70 | $92K | 154,806 |
| 2019-04-11 | Tubridy Karen L SVP, Chief Development Officer | Returned to the company | −6,075 | $7.70 | $47K | 55,324 |
| 2019-04-11 | Amello Jason SVP, CFO & Treasurer | Returned to the company | −13,148 | $7.70 | $101K | 118,618 |
Page 18 of 21 · 405 trades